Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-02 @ 12:20 AM
Study NCT ID:
NCT05903703
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-15
First Post:
2023-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canagliflozin With Gemcitabine in Pancreatic Carcinoma
Sponsor:
Zhang Xiaofeng,MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-19
First Submit QC Date:
None
Study First Post Date:
2023-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-11
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL